# Demcon

> Demcon is a VC fund in Enschede backing Manufacturing and Chemical. See 6 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Enschede, The Netherlands
- Total investments: 6
- Last investment: Mar 2026
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/demcon/
- X (Twitter): https://twitter.com/DEMCON
- Website: http://www.demcon.nl
- Facebook: https://www.facebook.com/theDEMCONgroup

Demcon is a VC fund in Enschede focused on Manufacturing and Chemical. Demcon supplies high-end technology products and systems such as optomechatronic, robotic and medical systems.

## Contacts

5 contacts available for Demcon. Shizune tracks 5 team members at Demcon. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/demcon?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 3 | 50% |
| Chemical | 2 | 33% |
| Health Care | 2 | 33% |
| Biotechnology | 2 | 33% |
| Nanotechnology | 2 | 33% |

17 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Venture - Series Unknown | 2 | 33% |
| Grant | 1 | 17% |
| Series A | 1 | 17% |
| Series B | 1 | 17% |
| Funding Round | 1 | 17% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Barth Vrijling | sr Industrial Design Engineer | 0 | — |
| Dennis Schipper | Co-Founder & Managing Director | 0 | — |
| Fedor Ester | Managing Director & Founder | 0 | — |
| Paul Zawierka | Founder | 0 | — |
| Peter Rutgers | Co-Founder & Mechatronics Consultant | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Scinus Cell Expansion | Scinus Cell Expansion develops and distributes bioreactor technology for stem cell cultivation. If you want would contact them please contact them via phone call or email. | $3.4M | Venture - Series Unknown | Mar 16, 2026 |  |
| Thorizon | Thorizon has rapidly evolved from a spin-off of NRG (Dutch Nuclear Research Institute) into an ambitious deep-tech startup, with offices in Amsterdam and Lyon. The company views small modular nuclear reactors as an ideal, stable, and clean contributor to an energy system where wind and solar are the other important sources. The ambition is todevelop a reactor based on molten salt that can be realized rapidly and smartly, is ’walk-away’ safe, and takes a first step towards circularity by using long-lived nuclear waste as a fuel source. Thorizon is working to further strengthen its financial position to be able to build a non-nuclear molten salt demonstrator in the short term and finalize the detailed design to start building a first-of-a-kind reactor by 2030: the Thorizon One. Thorizon partners with industry leaders like Orano, Tractebel and EDF to advance its design and is a laureate in the France 2030 program for advanced nuclear projects. For more information about Thorizon, you can visit www.thorizon.com | $4.4M | Grant | Mar 12, 2025 |  |
| Enzyre | Enzyre is a developer of diagnostic technology. | $11.8M | Series A | Nov 02, 2022 |  |
| In Ovo | In Ovo combines animal welfare and efficiency by offering biotechnological solutions to the poultry industry. We currently focus on a long existing problem in hatcheries: The culling of one day old male chickens. Our solution, a gender screening in the first half of the breeding process, has several advantages. It prevents a lot of stress thechickens experience during the current manual gender sorting process, it reduces the energy consumption and CO2 emission of the hatchery and prevents the need to kill one day old chickens. This way, we make hatcheries more animal friendly and sustainable, and increase the efficiency at the same time. | $37.8M | Series B | Mar 01, 2022 |  |
| Eurekite | Eurekite is a scientific and creative company with expertise in formulation chemistry, production technology, and composite development.The company was incorporated in May 2015 as a spin off from the university to further develop and commercialize the technology. The disruptive flexible ceramic technology attracted Cottonwood Technology Fund, atop performing early stage VC firm from U.S.Eurekite’s birthplace is the University of Twente, which is located in Enschede, The Netherlands. The Flexiramics® technology was developed at the Inorganic Materials Science Group (IMS) of MESA + Institute for Nanotechnology, under the supervision of Prof. Andre ten Elshof. | $2.2M |  | Feb 01, 2021 |  |
| Flexiramics | Flexiramics combines ceramic properties such as heat resistance and chemical stability with the flexibility and lightweight characteristics typically associated with polymers. The company supports use cases including high-frequency electronics, thermal management, battery components, and advanced filtration media. It collaborates with partners toco-develop materials tailored to specific performance and manufacturing requirements. Its offerings also extend to advisory and technical support for integrating these materials into commercial products. | $2.4M | Venture - Series Unknown | Feb 01, 2021 |  |

6 of 6 investments shown.

## Co-investors
- [OostNL](https://shizune.co/investors/profile/oostnl) — VC Fund, 3 deals together
- [Lumana Invest](https://shizune.co/investors/profile/lumana-invest) — VC Fund, 2 deals together
- [ABN AMRO Fund](https://shizune.co/investors/profile/abn-amro) — VC Fund, 1 deal together
- [European Circular Bioeconomy Fund](https://shizune.co/investors/profile/european-circular-bioeconomy-fund) — VC Fund, 1 deal together
- [Evonik Venture Capital](https://shizune.co/investors/profile/evonik-venture-capital-gmbh) — VC Fund, 1 deal together
- [i&i Biotech Fund](https://shizune.co/investors/profile/i-i-biotech-fund) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund

## FAQ

### What does Demcon invest in?

Demcon invests primarily in Manufacturing, Chemical and Health Care startups, most often at Venture - Series Unknown and Grant stage. Most of the 6 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Demcon?

Public channels for Demcon include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Demcon?

The team at Demcon includes Barth Vrijling (sr Industrial Design Engineer), Dennis Schipper (Co-Founder & Managing Director) and Fedor Ester (Managing Director & Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co